Year: 2024

EDINBURG, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced third quarter 2024 financial and operating results. Third Quarter 2024 HighlightsGlo Fiber Expansion Markets1 experienced growth in a number of key metrics:Added approximately 6,000 subscribers in the third quarter of 2024, ending the quarter with over 59,000 subscribers. Passings grew approximately 22,000 to a total of approximately 320,000. Revenue grew $5.8 million or 62% to $15.1 million compared to the same period in 2023. Excluding Horizon markets, revenue grew 56% over the same period in 2023.Integration of Horizon ahead of schedule and on track to exceed synergy targets.“We had a record quarter for Glo Fiber net additions and revenue driving top line revenue growth.” said President...

Third Quarter 2024 HighlightsRevenue increased 27% to €255 million Profit for the period increased €33 million to €37 million and expanded to 14.5% as a percentage of revenue Adjusted EBITDA1 increased 30% to €66 million and Adjusted EBITDA margin1 expanded to 25.8% Net cash generated from operating activities increased 55% to €118 million and Free cash flow1 increased 192% to €62 million Customer Net Retention Rate1 increased to 126% Repurchased $8.3 million of shares Further raised full year guidance to revenue growth of at least 24% to €1,090 million and Adjusted EBITDA growth of at least 29% to €216 millionST. GALLEN, Switzerland, Nov. 07, 2024 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports...

CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2024. Third Quarter HighlightsThird quarter 2024 net revenues of $118.3 million, a $13.7 million decrease compared to $132.0 million in the prior year period. Third quarter 2024 Submissions were 166,195, a 2.9% increase compared to 161,550 Submissions in the prior year period, with strong contributions from GoHealth’s internal captive agents, partially offset by a decline in Submissions from the external GoPartner Solutions (“GPS”) agents. Third quarter 2024 net income of $15.4 million, an improvement of $71.6 million compared to a net loss of $56.2 million in...

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) — Marex Group plc (‘Marex’ or the ‘Group’; Nasdaq: MRX), a diversified global financial services platform, announces strong results for the third quarter (Q3) and nine months (9M) ended 30 September 2024, and upgraded outlook for the full year. Financial HighlightsFinancial Highlights: ($m) 3 months ended 30 September 2024   3 months ended 30 September 2023   Change1   9 months ended 30 September 2024   9 months ended 30 September 2023   Change1Reported                      Revenue 391.2   296.6           32%   1,179.1   919.0           28%Profit Before Tax 79.0   47.6           66%   218.0   157.1           39%Profit Before Tax Margin (%)         20%           16%   400 bps           18%           17%   100 bpsProfit After Tax 58.4   32.4           80%   161.3   113.2           42%Profit...

         24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024 38% Revenue growth over third quarter 2023 and 22% Recurring revenue growth in twelve-month trailing average Worldwide procedure volumes increased 29% over third quarter of 2023 Installed system base grew 20% over third quarter of 2023 ORLANDO, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) — LENSAR®, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2024 and provided an update on key operational initiatives. “Our third quarter results further show the continued momentum...

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s portfolio of 60-plus licensed early-stage assets across approximately 30 partners Cash receipts totaled $9.9 million in the third quarter, and $42.3 million for the first nine months of 2024 EMERYVILLE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, reported its third quarter 2024 financial results and highlighted recent activities. “We continue to take a balanced approach to building a portfolio of sustainable cashflow streams by selectively acquiring royalty economics across the lifecycle of drug development,” stated Owen Hughes, Chief Executive Officer of XOMA...

MONTREAL, Nov. 07, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2024. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. Q3 2024 Highlights Financial ResultsDelivered revenues of $92,263, an increase of $10,763 or 13% or $13,801 or 18% on a constant currency1 basis, over the same period in the prior year. The increase is driven by growth of our key promoted products partly offset by declines of our mature products. Gross margin of $45,017 or 49% of revenues compared to $40,182 or 49% of revenues in the same period in the prior year. Adjusted EBITDA1 was...

Following the sale of European staffing operations, Q3 revenue down 7.1% year-over-year; nearly flat on an organic basis Q3 operating earnings of $2.6 million; $11.7 million on an adjusted basis, down 24.5% Q3 adjusted EBITDA margin increased 20 basis points to 2.5% Company expects sale of European staffing operations, acquisition of Motion Recruitment Partners, LLC (“MRP”), ongoing transformation actions to contribute to continued year-over-year EBITDA margin expansion in Q4 2024TROY, Mich., Nov. 07, 2024 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the third quarter of 2024. Peter Quigley, president and chief executive officer, announced revenue for the third quarter of 2024 totaled $1.04 billion, a 7.1% decrease compared to the corresponding...